GlassScriptPhysician profile
Sarah Hai
NPI 1497204317
$5,004.40
in general payments reported to CMS, 2019-2025
22 companies · $182 in 2025
The $182 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,031 · 2022: $1,172 · 2023: $106 · 2024: $513 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $801.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,052.60 | 2021-2025 | Xifaxan |
| Janssen Biotech, INC. | $974.49 | 2021-2022 | |
| Abbvie INC. | $684.05 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $494.14 | 2021-2024 | Eohilia, Entyvio, Gattex |
| Pfizer INC. | $294.80 | 2021-2022 | |
| Qol Medical, LLC | $241.12 | 2021-2024 | Sucraid |
| Nestle Healthcare Nutrition INC. | $227.99 | 2021-2022 | |
| Celgene Corporation | $187.94 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $142.23 | 2024-2025 | Dupixent |
| Redhill Biopharma INC. | $132.06 | 2021 | |
| Gilead Sciences, INC. | $129.05 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $87.01 | 2021-2024 | Dificid |
| Genzyme Corporation | $68.51 | 2024 | |
| Intercept Pharmaceuticals, INC. | $68.10 | 2021-2022 | |
| Ironwood Pharmaceuticals, INC | $53.00 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $48.76 | 2024 | Ibsrela |
| Daiichi Sankyo INC. | $34.06 | 2021 | |
| Phathom Pharmaceuticals, INC. | $23.28 | 2024 | Voquezna |
| Mallinckrodt Hospital Products INC. | $18.30 | 2022 | |
| Ferring Pharmaceuticals INC. | $15.36 | 2022 | |
| Evoke Pharma, INC. | $15.03 | 2021 | |
| Braintree Laboratories, INC. | $12.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Hai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.